| Name | Title | Contact Details |
|---|---|---|
Mehran Mosbriantanha |
Vice President of Information Services | Profile |
Christian Health Care Center (CHCC) has been fostering health, healing and wellness in northern New Jersey for more than 100 years. Since its inception, CHCC has grown to offer the most complete continuum of senior living, elder-care, short-term rehabilitation, and mental-health services available on any campus in the area, and serves as a vital source of services and information for clients, residents, patients, consumers, and their sponsors. Our commitment to caring begins with recognizing the intrinsic value of all individuals and helping each person reach his or her highest potential for health, healing, and wellness. In so doing, we seek not only to meet each person`s physical needs, but also to nurture emotional and spiritual well-being. Situated on 78 acres overlooking the Ramapo Mountains, CHCC is a non-profit organization that serves all people, regardless of race, sex, or religion. CHCC has expanded to meet the changing needs of the community and continues to offer care in a compassionate and loving environment consistent with the Christian values upon which we were founded. Senior Life Services include: Independent living (Wyckoff and Wayne), Supportive senior living, Adult day services (Wyckoff and Wayne), Assisted living Memory support, Skilled nursing, Behavior management. Short-term Rehabilitation: Post-acute care including rehabilitation therapy and skilled nursing. Mental-Health Services include: Inpatient psychiatric hospital, Short-term partial-hospitalization program, Outpatient counseling for people of all ages. The Vista: An independent-living community for active adults age 62 and over.
Studio Three encompasses 3 unique fitness studios under the same roof: Interval, Cycle & Yoga; which can be tailored to the fitness level of any individual.
Hospicom is a Cold Spring, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.